ANNOUNCEMENT REGARDING RAFARMA PHARMACEUTICALS' NEW COMBINED ANNUAL AUDIT
Due to changes in international regulation, the Company was forced to radically reorganize its strategy and structure. Consolidation with...
ANNOUNCEMENT REGARDING RAFARMA PHARMACEUTICALS' NEW COMBINED ANNUAL AUDIT
Revolutionizing Cancer Treatment: The Promise of Yttrium-90 Microspheres in Radioembolization Therapy
Next Steps for Yttrium-90 Microspheres Registration in South Korea and China for Liver Cancer Treatment
Shareholders Meeting - Official Responses of Chairman Iliya Shpurov
Rafarma pharmaceutical updates: agreements with Shri Lanka pharmaceutical company Kelun Lifescience
Rafarma Pharmaceutical news update
Rafarma Pharmaceuticals Signed a Preliminary Agreement for Radiopharmaceutical Production Center
Rapharma and Kelun Lifesciences have entered into a preliminary agreement
Rafarma Pharmaceuticals plans to open an enterprise in Hong Kong